|Videos|December 15, 2015
- Breast Cancer (Issue 2)
- Volume 1
- Issue 2
Dr. Carey Anders on Treating Brain Metastases in Breast Cancer
Author(s)Carey Anders, MD
Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, on the challenge of treating brain metastases in breast cancer. Anders says brain metastases generally portend a poor prognosis and treatment for them are currently scarce.
Advertisement
Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, on the challenge of treating brain metastases in breast cancer. Anders says brain metastases generally portend a poor prognosis and treatment for them are currently scarce.
Articles in this issue
about 10 years ago
Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast Cancerabout 10 years ago
Avelumab Shows Efficacy in PD-L1-Positive Metastatic Breast CancerAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
5
